These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 24094627)

  • 1. Reduction in cardiac volume during chemoradiotherapy for patients with esophageal cancer.
    Lutkenhaus LJ; Kamphuis M; van Wieringen N; Hulshof MC; Bel A
    Radiother Oncol; 2013 Nov; 109(2):200-3. PubMed ID: 24094627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in cardiac volume determined with repeated enhanced 4DCT during chemoradiotherapy for esophageal cancer.
    Wang X; Wang JZ; Li JB; Zhang YJ; Li FX; Wang W; Guo YL; Shao Q; Xu M; Liu XJ; Wang Y
    Radiat Oncol; 2018 Sep; 13(1):181. PubMed ID: 30227865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of heart volume during neoadjuvant chemoradiation in patients with resectable esophageal cancer.
    Haj Mohammad N; Kamphuis M; Hulshof MC; Lutkenhaus LJ; Gisbertz SS; Bergman JJ; de Bruin-Bon HA; Geijsen ED; Bel A; Boekholdt SM; van Laarhoven HW
    Radiother Oncol; 2015 Jan; 114(1):91-5. PubMed ID: 25630429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac volume effects during chemoradiotherapy for esophageal cancer (Regarding Lutkenhaus et al. Reduction in cardiac volume during chemoradiotherapy for patients with esophageal cancer).
    Edmunds K; Brooks C; Hansen VN; Harris V; Tait DM
    Radiother Oncol; 2015 Jan; 114(1):128-9. PubMed ID: 25497875
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute cardiac impairment associated with concurrent chemoradiotherapy for esophageal cancer: magnetic resonance evaluation.
    Hatakenaka M; Yonezawa M; Nonoshita T; Nakamura K; Yabuuchi H; Shioyama Y; Nagao M; Matsuo Y; Kamitani T; Higo T; Nishikawa K; Setoguchi T; Honda H
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e67-73. PubMed ID: 22365626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient setup error and day-to-day esophageal motion error analyzed by cone-beam computed tomography in radiation therapy.
    Yamashita H; Haga A; Hayakawa Y; Okuma K; Yoda K; Okano Y; Tanaka K; Imae T; Ohtomo K; Nakagawa K
    Acta Oncol; 2010 May; 49(4):485-90. PubMed ID: 20230211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for pericardial effusion in patients with stage I esophageal cancer treated with chemoradiotherapy.
    Tamari K; Isohashi F; Akino Y; Suzuki O; Seo Y; Yoshioka Y; Hayashi Y; Nishida T; Takehara T; Mori M; Doki Y; Ogawa K
    Anticancer Res; 2014 Dec; 34(12):7389-93. PubMed ID: 25503178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of chemoradiotherapy for Stage II and III( non-T4) esophageal cancer].
    Ishiguro T; Kumagai Y; Kumamoto K; Baba H; Ishibashi K; Haga N; Tsuji Y; Ishida H
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2092-4. PubMed ID: 23267987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regarding Edmunds et al. Cardiac volume effects during chemoradiotherapy for esophageal cancer.
    Lutkenhaus LJ; Kamphuis M; van Wieringen N; Hulshof MC; Bel A
    Radiother Oncol; 2015 Jan; 114(1):130. PubMed ID: 25583569
    [No Abstract]   [Full Text] [Related]  

  • 10. Residual setup errors and dose variations with less-than-daily image guided patient setup in external beam radiotherapy for esophageal cancer.
    Han C; Schiffner DC; Schultheiss TE; Chen YJ; Liu A; Wong JY
    Radiother Oncol; 2012 Feb; 102(2):309-14. PubMed ID: 21872956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical therapy and chemoradiotherapy for postoperative recurrent esophageal cancer.
    Kubota K; Kuroda J; Yoshida M; Ohta K; Suwa T; Mafune K; Kawase T; Kitahara T; Kubo A; Kitajima M
    Hepatogastroenterology; 2013; 60(128):1961-5. PubMed ID: 24719935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemoradiotherapy followed by surgery in treatment of locally advanced esophageal carcinoma: a phase II trial].
    Fu JH; Rong TH; Li XD; Hu Y; Ou W; Hu YH; Li Q
    Ai Zheng; 2004 Nov; 23(11 Suppl):1473-6. PubMed ID: 15566661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent chemoradiotherapy for esophageal carcinoma patients with malignant fistulae.
    Muto M; Ohtsu A; Miyamoto S; Muro K; Boku N; Ishikura S; Satake M; Ogino T; Tajiri H; Yoshida S
    Cancer; 1999 Oct; 86(8):1406-13. PubMed ID: 10526266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of concurrent chemoradiotherapy at the dose of 50.4 Gy with elective nodal irradiation for Stage II-III esophageal carcinoma.
    Kato K; Nakajima TE; Ito Y; Katada C; Ishiyama H; Tokunaga SY; Tanaka M; Hironaka S; Hashimoto T; Ura T; Kodaira T; Yoshimura K
    Jpn J Clin Oncol; 2013 Jun; 43(6):608-15. PubMed ID: 23585687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Definitive chemoradiotherapy for esophageal cancer: 66Gy versus 50Gy, a retrospective study].
    Clavier JB; Antoni D; Atlani D; Ben Abdelghani M; Schumacher C; Salze P; Noël G
    Cancer Radiother; 2013 Jun; 17(3):221-8. PubMed ID: 23684111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoradiotherapy with and without esophagectomy for advanced esophageal cancer.
    Nakamura T; Ota M; Hayashi K; Eguchi R; Ide H; Takasaki K; Mitsuhashi N
    Hepatogastroenterology; 2006; 53(71):705-9. PubMed ID: 17086873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Esophageal carcinosarcoma treated with surgery and chemoradiotherapy-a report of 4 cases].
    Takemoto K; Shiozaki A; Fujiwara H; Shimizu H; Konishi H; Komatsu S; Kubota T; Ichikawa D; Okamoto K; Morimura R; Murayama Y; Ikoma H; Kuriu Y; Nakanishi M; Sakakura C; Otsuji E
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2106-8. PubMed ID: 24394028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of a randomized Phase II study of cisplatin/5-FU concurrent chemoradiotherapy for esophageal cancer (KROSG0101/JROSG021).
    Nishimura Y; Hiraoka M; Koike R; Nakamatsu K; Itasaka S; Kawamura M; Negoro Y; Araki N; Ishikawa H; Fujii T; Mitsuhashi N
    Jpn J Clin Oncol; 2012 Sep; 42(9):807-12. PubMed ID: 22811410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esophageal bypass operation prior to definitive chemoradiotherapy in advanced esophageal cancer with tracheobronchial invasion.
    Hihara J; Hamai Y; Emi M; Aoki Y; Taomoto J; Miyata Y; Okada M
    Ann Thorac Surg; 2014 Jan; 97(1):290-5. PubMed ID: 24200399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment-related acute esophagitis for patients with locoregionally advanced non-small cell lung cancer treated with involved-field radiotherapy and concurrent chemotherapy.
    Bar-Ad V; Leiby B; Witek M; Xiao Y; Cui Y; Dai Y; Cao J; Axelrod R; Campling B; Both S; Werner-Wasik M
    Am J Clin Oncol; 2014 Oct; 37(5):433-7. PubMed ID: 23388558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.